Abstract
To meet the goals of converging molecular imaging with molecular biology and molecular medicine, there is a need to define the strategy and structure for perfecting the accuracy of functional images derived using PET. This also relates directly to how clinical research, diagnostic questions and challenges from the pharmaceutical industry are addressed. In order to exploit the sensitivity and specificity of PET, an integrated, multidisciplinary approach is imperative. The structure to provide this needs to been seen in the context of an institutional approach, collaborations within the academic and industrial sectors and the funding needed to meet the challenges of addressing difficult questions.